Some individuals have genetic variants in their GLP-1 receptor gene (such as rs6923761) that affect how powerfully this hormone influences their appetite and glucose control
11: Sikiric P, Seiwerth S, Skrtic A, Staresinic M, Strbe S, Vuksic A, Sikiric S, Bekic D, Penovic T, Drazenovic D, Becejac T, Tepes M, Madzar Z, Novosel L, Beketic Oreskovic L, Oreskovic I, Stupnisek M, Boban Blagaic A, Dobric I
By lowering the inflammation burden, the MD may help improve tolerability and enhance semaglutides efficacy in improving glycaemic and metabolic outcomes, especially in patients with high inflammatory burden, metabolic syndrome, or comorbid inflammatory conditions [125, 126]
Uyar: Bu haber yalnzca bilgilendirme amacyla hazrlanmtr